FDA's Schwetz Is Acting Commissioner: RU-486 Appears To Be Touchstone
Executive Summary
FDA Acting Deputy Commissioner Bernard Schwetz, PhD, will oversee the agency following the resignation of Commissioner Jane Henney, MD.
You may also be interested in...
FDA’s Torti Tapped As Acting Commissioner; Interim Heads Also Named For HHS, CMS
Chief scientist Frank Torti is a relative newcomer to FDA, having joined less than a year ago from Wake Forest University. Since then, he has headed the agency’s successful fellowship program.
FDA’s Interim Commissioner: Manager or Scientist?
FDA Chief Scientist Frank Torti fits the profile of an interim commissioner if the incoming administration wants a caretaker with a solid scientific stature and also little baggage of the past regime
FDA’s Interim Commissioner: Manager or Scientist?
FDA Chief Scientist Frank Torti fits the profile of an interim commissioner if the incoming administration wants a caretaker with a solid scientific stature and also little baggage of the past regime